Malanovic, N.; Birarda, G.; Eder, S.; Gruber-Woelfler, H.; Reiter, F.; Juraic, K.; Hodzic, A.
Small-Angle X-ray Scattering (SAXS) Used for the Identification of Nicomorphine Polymorphic Changes at the Early Stage to Avoid Varied Stability and Possible Side Effects. Pharmaceuticals 2024, 17, 375.
https://doi.org/10.3390/ph17030375
AMA Style
Malanovic N, Birarda G, Eder S, Gruber-Woelfler H, Reiter F, Juraic K, Hodzic A.
Small-Angle X-ray Scattering (SAXS) Used for the Identification of Nicomorphine Polymorphic Changes at the Early Stage to Avoid Varied Stability and Possible Side Effects. Pharmaceuticals. 2024; 17(3):375.
https://doi.org/10.3390/ph17030375
Chicago/Turabian Style
Malanovic, Nermina, Giovanni Birarda, Simone Eder, Heidrun Gruber-Woelfler, Franz Reiter, Krunoslav Juraic, and Aden Hodzic.
2024. "Small-Angle X-ray Scattering (SAXS) Used for the Identification of Nicomorphine Polymorphic Changes at the Early Stage to Avoid Varied Stability and Possible Side Effects" Pharmaceuticals 17, no. 3: 375.
https://doi.org/10.3390/ph17030375
APA Style
Malanovic, N., Birarda, G., Eder, S., Gruber-Woelfler, H., Reiter, F., Juraic, K., & Hodzic, A.
(2024). Small-Angle X-ray Scattering (SAXS) Used for the Identification of Nicomorphine Polymorphic Changes at the Early Stage to Avoid Varied Stability and Possible Side Effects. Pharmaceuticals, 17(3), 375.
https://doi.org/10.3390/ph17030375
